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INTRODUCTION
Lacrimal gland (LG) secretion of proteins and fluid into the tear 
film is essential for maintaining the health of the ocular surface (OS). 
With regard to the corneal epithelium, its smooth optical properties, 
its transparency, and its protective effect against pathogenic infiltra-
tion are sustained by lacrimal gland functions(1,2). Tears are a complex 
mixture of various constituents containing more than a thousand 
different proteins(3). Lysosomal hydrolases, secretory IgA(4), lactoferrin, 
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Purpose: In the lacrimal gland (LG) acinar cells, signaling regulates the release of 
secretory vesicles through specific Rab and SNARE exocytotic proteins. In diabetes 
mellitus (DM), the LGs are dysfunctional. The aim of this work was to determine 
if secretory apparatus changes were associated with any effects on the secretory 
vesicles (SV) in diabetic rats as well as the expression levels of constituent Rab 
and members of the SNARE family, and if insulin supplementation reversed those 
changes. 
Methods: DM was induced in male Wistar rats with an intravenous dose of strepto-
zotocin (60 mg/kg). One of the two diabetic groups was then treated every other 
day with insulin (1 IU). A third control group was injected with vehicle. After 10 
weeks, Western blotting and RT-PCR were used to compared the Rab and SNARE 
secretory factor levels in the LGs. Transmission electron microscopy evaluated 
acinar cell SV density and integrity. 
Results: In the diabetes mellitus group, there were fewer and enlarged SV. The Rab 
27b, Rab 3d, and syntaxin-1 protein expression declined in the rats with diabetes 
mellitus. Insulin treatment restored the SV density and the Rab 27b and syntaxin 
expression to their control protein levels, whereas the Vamp 2 mRNA expression 
increased above the control levels. 
Conclusions: Diabetes mellitus LG changes were associated with the declines in 
protein expression levels that were involved in supporting exocytosis and vesicular 
formation. They were partially reversed by insulin replacement therapy. These fin-
dings may help to improve therapeutic management of dry eye in diabetes mellitus.
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RESUMO
Objetivo: Células acinares da glândula lacrimal (GL) sinalizam a regulação da libe-
ração através de vesículas secretórias específicas Rab proteínas exocitóticas SNARE. 
No diabetes mellitus (DM), as glândulas lacrimais são disfuncionais. O objetivo deste 
trabalho foi determinar se em ratos diabéticos, alterações dos aparatos secretórios 
estão associados a efeitos sobre vesículas secretoras (VS) e sobre os níveis de expressão 
do constituinte Rab, bem como membros da família SNARE, e se a suplementação de 
insulina reverte as alterações. 
Métodos: DM foi induzido em ratos Wistar machos com uma dose intravenosa de 
estreptozotocina (60 mg/kg). Um dos dois grupos diabéticos foi então tratado a cada 
dois dias com insulina (1 UI). Um terceiro grupo controle foi injetado com o veículo. 
Após 10 semanas, western blot e RT-PCR comparou níveis de fatores secretórios de Rab 
e SNARE na glândula lacrimal. Microscopia eletrônica de transmissão (MET ) avaliaram 
a densidade e integridade de VS de célula acinar. 
Resultados: No grupo diabetes mellitus , houve poucas e alargadas VS. Rab27b, Rab 
3d e Sintaxina-1 diminuiu a expressão da proteína em ratos com Diabetes Mellitus. 
O tratamento com insulina restaurou a densidade das VS e expressão de Rab 27b e 
Sintaxina para seus níveis de proteína controle, enquanto a expressão de Vamp 2 RNAm 
aumentou em relação aos controles. 
Conclusões: Alterações na glândula lacrimal de diabetes mellitus estão associadas 
a reduções nos níveis de expressão de proteínas envolvidas no apoio a exocitose e 
formação vesicular. Eles são, em parte, revertida por terapia de reposição de insulina. 
Estes resultados podem ajudar a melhorar a conduta terapêutica do olho seco no 
diabetes mellitus. 
Descritores: Diabetes Mellitus/induzido quimicamente; Aparelho lacrimal; Exocitose; 
Vesículas secretórias; Proteínas R-SNARE; Animais; Ratos
transferrin(5), and growth factors are secreted through vesicles or gra-
nules in a regulated or constitutive manner(6).
Diabetes mellitus (DM) impairs tear secretion and induces LG and 
OS changes(7). Although the effects of DM-induced hyperglycemia, 
oxidative stress, nerve damage, and impaired insulin signaling have 
been described in the LG, changes in the secretory mechanism cau-
sed by this disease are not clearly understood(8,9). A recent work re-
vealed that high glucose levels reduced the expression of secretory 
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granule-associated vesicle-soluble N-ethylmaleimide-sensitive factor 
attachment protein receptors (SNARE) in the pancreatic beta-cells(10). 
Metabolic and neurogenic inputs are needed to sustain LG function. 
Specifically, they control secretory and anti-oxidant mechanisms(11,12). 
Such support is needed to enable the secretory products in the lacri-
mal acini to go through sorting into immature secretory vesicles in 
the trans-Golgi network and to acquire the external proteins charac-
teristic of mature secretory vesicles (SVs) as they move towards the 
apical membrane prior to their exocytotic release(13).
Local and systemic pathways highly control the LG exocytosis of 
tear fluid components. The exocytosis is modulated by cholinergic 
and adrenergic stimuli, through changes in protein-kinase A (PKA) 
activity and intracellular calcium transients(14). This process has several 
diverse roles, including the release of neurotransmitters, hormones, 
enzymes, and cytokines. It is regulated in the intracellular environment 
by a group of cytosolic proteins that include receptors specific for 
anchoring vesicles. SNAREs and some Rab GTPases participate in this 
process and comprise proteins responsible for mediating secretion 
from neural, endocrine, and other exocrine tissues(15). They include 
vesicle-associated membrane protein 2 (Vamp2), Rab 3d, and syn-
taxin 1, which are responsible for the docking of molecules and the 
driving of the plasma membrane vesicle fusion that leads to the 
release of their soluble components into tears(16).
In the LG, the most abundant protein in the acinar secretory pathway 
is Rab3, which is localized to mature SVs. This protein drives vesicular 
docking and apical membrane fusion and it can also play a role in 
de termining vesicular size(17) (Figure 1). In previous studies, aging rats 
had presented with dry eye disease, an insulin-signaling im pairment, 
oxidative stress, and declines in the parasympathetic control of LG 
function; this revealed an interesting similarity with DM dry eye(18,19). 
Some SNARE and Rab family members were also altered in aged LG; 
particularly, Rab 3 expression was reduced at both the mRNA and 
protein levels(20). In addition, advanced glycation end pro ducts can 
accumulate in aged and diabetic rat LGs(7,18).
In the current study, we characterized the impact of DM on rat 
LG acetylcholine (ACh) content, the expression of Rab and SNARE 
family proteins, and the structure of secretory vesicles (SV) as well as 
the protective effects rendered by insulin supplementation on such 
changes.
METHODS
AnimAl model
Eight-week-old male Wistar rats were obtained from the Animal 
Breeding Center of the Faculty of Medicine of Ribeirão Preto (Ribei-
rão Preto, São Paulo, Brazil). The animals had free access to standard 
rodent chow and water. Food was withdrawn 12 h before the experi-
ments and diabetes was induced with a single dose of streptozotocin 
(Sigma, St. Louis, MO, USA), 60 mg/kg body weight, diluted in 1 mL of 
0.01 M citrate buffer that was administered through the caudal vein. 
Controls were injected with citrate buffer alone. Each of the three 
different groups used 10 rats.
Two days later, the diabetic status was verified with a glucose 
meter test (Accu-check, Roche Diagnostica Brazil Ltda., São Paulo, SP, 
Brazil) of blood obtained from the caudal veins of rats that had fasted 
for 12 h. A fasting hyperglycemia of over 200 mg/dL was thought to 
indicate the presence of diabetes; on the 4th day, insulin treatment 
was initiated in part of the diabetic group (subcutaneous injections 
of 1 IU every other day). This dose was not sufficient to maintain ade-
quate glycemic control, but was enough to avoid body weight loss 
and growth retardation(21).
Comparative studies of the three groups, i.e., control (C), diabetic 
(DM), and diabetic with insulin treatment (IT), were performed 10 
weeks later.
The animals were weighed, anesthetized with intraperitoneal in-
jection comprising a combination of ketamine (5 mg/100 g b.w.) (União 
Química Farmacêutica S.A, Embu-Guaçu, SP, Brazil) and xylazine (2 mg/ 
100 g b.w.) (Laboratorio Callier S.A., Barcelona, Spain). LGs were ex-
tirpated after ensuring that the corneal and caudal reflexes were aboli-
shed. Thereafter, the rats were euthanized with excess anaesthesia.
Tissue collecTion And sTorAge
Each LG obtained from the right side of a rat was dissected into two 
parts and processed according to the protocol for each set of expe-
riments. LGs were collected and homogenized in a buffer containing 
50 mM Tris at a pH of 7.5, 500 mM NaCl, 0.1% Triton, and the protease 
inhibitor cocktail set III (Calbiochem, San Diego, CA) with a Polytron 
(Virsonic, Biopharma, Winchester, UK). RNA from the LGs was extrac-
ted with Trizol after homogenization, according to the manufacturer’s 
protocol. The left LG was used for transmission electron microscopy 
(EM). This tissue was fixed in 2% glutaraldehyde and 2% paraformal-
dehyde (Sciences, Hatfield, PA, USA) in 0.1 M of phosphate buffer at a pH 
of 7.4, for 40 min at room temperature.
AceTylcholine (Ach) meAsuremenTs in lg
ACh was measured in LG using an ACh assay kit (Amplex Red; 
Mo lecular Probes, Eugene, OR, USA) to compare the amounts of this 
neurotransmitter in LGs of the three groups (n=5/group)(22). In brief, 
0.1 mL of medium and tissue aliquots of homogenates containing 
200 µg of protein were spotted in duplicate onto 96-well microplates. 
Standard ACh curves were constructed to evaluate the ACh content 
in each experiment. A 0.1 mL aliquot of assay buffer (50 mM Tris-HCl 
at a pH of 7.5) containing 0.2 M of reagent (Amplex Red; Molecular 
Probes), 2 U/mL of horseradish peroxidase, 0.2 U/mL of choline oxida-
se, and 10 U/mL of acetylcholinesterase was added to each well. After 
incubation, absorbance was determined with a spectrophotometer 
(Beckman Instruments, Inc., Fullerton, CA) at 530 nm. The ACh levels 
were expressed on a millimolar (mM) basis.
Figure 1. Schematic figure of the protein trafficking in the acinar cell cytoplasm of the 
lacrimal gland (ACLG) that showed the role of the following SNARE proteins (SNAP (So-
luble NSF, N-ethylmaleimide sensitive fusion proteins, Attachment Protein Receptor”), 
Vamp-2 and syntaxin, and the Rab proteins 3, 23, and 27 b, that were previously described 
in this tissue. The figure indicates the caption of protein from the blood vessel (BV), 
the rough endoplasmic reticulum (RER), or the Golgi complex (GC) by a vesicle SNARE 
(v-SNARE), Vamp-2; this was transported into the secretory vesicle (SV) to the GC (where 
they were modified) or ready in the acinar cell cytoplasm, but coated by proteins that 
protected them for secretion (storage and regulated secretion). Once ready or requested 
by extracellular triggers, the SV was uncoated, and SNARE-v was anchored to target the 
SNARE (t-SNARE), syntaxin, where the docking and exocytosis included the protein in 
the tear secretion (regulated and constitutive).
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TrAnsmission elecTron microscopy
LG tissues from the three groups that were fixed for TEM were rin-
sed in a 0.1 M phosphate buffer, dehydrated through a graded ethanol 
series, rinsed in acetone, and embedded in an Embed 812 (EM Scien-
ces). Sections (60-70 nm) were cut with a diamond knife and stained 
for 25 min each in 2% uranyl acetate and 5 min in Reynolds’ lead citrate. 
Sections were examined with a TEM (Jeol, Jem 100cx, Tokyo, Japan). Pic-
tures were taken and converted to digital files (Hamamatsu, ORCA-HR 
Amtv542, Hamamatsu City, Japan). The intra cellular organelles, in-
cluding secretory vesicles and nuclei, were eva luated in each group. 
rT-pcr for rAb3d, rAb 23, rAb 27b, And VAmp2
The reverse transcriptase polymerase chain reaction (RT-PCR) com-
pared the Rab3d, Rab 23, Rab 27b, and Vamp 2 mRNA levels in the three 
rat LG groups. In addition, beta-actin mRNA was used for internal nor-
malization. The resulting RNA was quantified by spectrophotometry 
at 260 nm and the RNA integrity was evaluated on 6.6% formaldehy-
de and 1% agarose (Gibco/BRL) gels. Reverse transcriptase, oligo dT 
priming, and the Advantage RT-for-PCR kits from Clontech Labora-
tories Inc. (Palo Alto, CA, USA) were used for the cDNA transcription.
PCR amplification of cDNA was performed with a GeneAmp poly-
merase chain reaction (PCR) System 9700 (Applied Biosystems, Foster 
City, CA, USA) using 1.5 units of Taq DNA polymerase (Gibco/BRL), 0.3 mM 
each of dATP, dCTP, dGTP, and dTTP (Invitrogen), PCR buffer (Tris -Hcl 
60 mM, MgCl2 1.5 mM, NH
4
 SO
4
 pH10 15 mM) (Invitrogen), and 10 mM 
of 5’ and 3’ primers corresponding to rat Rab 3d, Rab 23, Rab 27b, 
Vamp2, and beta-actin cDNA (Life Technologies, Gaithersburg, MD, 
USA), after the preliminary assays identified the parameters to ensure 
that the products were in the linear range (Table 1). In all PCR proce-
dures, the positive and negative control cDNAs were run in parallel. 
Our attempts to detect syntaxin 1 mRNA were unsuccessful as in a 
previous study(23). 
The PCR program used the following cycle profile: denaturation 
for 1 min at 94°C, annealing for 1 min at the indicated temperatures, 
extension for 1.5 min at 72°C, and maximization of strand completion 
for 7 min at 72°C. Following amplification, the cDNA fragments were 
analyzed on 1% agarose gels containing a 100 bp DNA molecular 
weight ladder (Gibco/BRL) and were post-stained with ethidium bro-
mide to confirm the anticipated base pair (bp) sizes for Rab 3d, Rab 
27b, Rab 23, and Vamp 2, and beta-actin products.
Positive controls for Rab3d, Rab 23, Rab 27b, and Vamp 2 included 
cDNA isolated from rat pancreatic islets. Negative controls included 
samples without reverse transcriptase or samples of cDNA. The re-
sults were recorded on the Gel Doc system (Bio-Rad Laboratories, 
Ri chmond, CA, USA). The membranes were scanned and analyzed 
by Scion Image Analysis Software (Scion Corp, Frederick, MD, USA).
WesTern bloTTing 
Western blots evaluated Rab 27b, Rab 3d, Vamp 2, and syntaxin 
1 protein expression in cell lysates obtained from the rat LGs from 
the three different groups (n=5/group). LGs were solubilized in 1 mL 
of homogenization buffer containing the following: 100 mM-2-ami-
no-2-hydroxymethyl-propane-1,3-diol (Tris) (pH 7.5), 10 mM-sodium 
pyrophosphate, 100 mM-sodium fluoride, 10 mM-EDTA, 10 mM-so-
dium vanadate, 2 mM-phenylmethylsulfonyl fluoride, and 1% Triton-X 
100. LGs were disrupted using a Polytron PT 1200C homogenizer 
(Brinkmann Instruments, Westbury, NY, USA). The extracts were then 
centrifuged at 12,000 rpm at 4°C for 15 min to remove insoluble ma-
terials. Protein concentrations in the supernatant fractions were 
assayed with the Bradford dye method. For SDS gel electrophoresis 
and Western blotting, the samples were treated with a Laemmli sam-
ple buffer containing dithiothreitol. After heating at 95°C for 5 min, 
the proteins were separated by electrophoresis (70 µg protein/lane, 
10%-12% gels). Following electrophoresis, the proteins were trans-
Table 1. RT-PCR primers and parameters for SNARE and Rab mRNA detection in LG. of control, DM, and insulin-treated DM rats
Accession number Primers sequence Number of cycles BP size Annealing temperature
Β-actin NM 031144 Sense: 5’  33 202 59°C
agagggaaatcgtgcgtgaca 3’
Antisense: 5’ 
cgatagtgatgacctgaccgtca 3’
Rab 3 d NM 080580 Sense: 5’ 37 340 59°C
actgatggtgacaatgatgc 3’
Antisense: 5’
acggaagtgaagaaagcaac 3’
Rab 23 NM 016277 Sense: 5’ 37 270 57°C
tgagccaaattgtgctgttc 3’
Antisense: 5’
gggcaataatttttccacca
Rab 27b NM 053459 Sense: 5’ 37 225 60°C
cggagctcgagaagactaga 3’
Antisense: 5’
ggccaggagtttaatcaggt 3’
Vamp 2 NM 012663 Sense: 5’ 34 141 58°C
gcatctctcctaccctttca 3’
Antisense: 5’
tttaggggtctgagggtaca 3’
Syntaxin NM 053788 Sense: 5’ 37 260 60°C
gtacaacgccactcagtcag 3’
Antisense 5’
agcatgtcttccaactcctc 3’
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ferred to nitrocellulose membranes. The nitrocellulose filters were 
trea ted with a blocking buffer (5% non-fat dried milk, 10 mM-Tris, 
150 mM-NaCl, and 0.02% Tween 20) overnight and were subsequen-
tly incubated with rabbit polyclonal antibody anti-Rab 3d, Vamp 2, 
Rab 27b, syntaxin 1, and GAPDH as internal controls (Table 2). Vi-
sua lization of specific protein bands was performed by incubating 
the membranes for 2 h with a peroxidase-conjugated secondary 
an tibody (1:10.000; Zymed Laboratories, Inc., San Francisco, CA, USA), 
followed by detection with enhanced chemiluminescence reagents 
(Pierce Biotechnology, Rockford, IL, USA) and exposure to X-ray film 
(Kodak, Manaus, AM, Brazil). The band intensities were quantified by 
optical densitometry (Scion, Image, Frederick, MD, USA).
sTATisTicAl AnAlysis
Data were reported as mean ± SEM. Comparisons were made 
using the Kruskal-Wallis test followed by Dunn’s post hoc test (GraphPad 
5.0 software; Prism, San Diego, CA). Densitometry values were repor-
ted as ratios of beta-actin in RT-PCR and GAPDH in the Western blot 
assays, respectively. The ratio of densitometric values of one control 
sample of each blot was defined as 1.0 (100%), and the subsequent 
values were expressed as a ratio relative to its control value and sub-
mitted to statistical analysis with the Kruskal-Wallis test followed by 
the Dunn’s post hoc test. 
RESULTS
Body and LG weight were significantly lower in the DM group 
than in its control group whereas insulin treatment prevented such 
declines. The ACh levels remained unchanged at 10 weeks after DM 
induction (Table 3).
In the apical areas of the acinar cells in the DM group, there were 
fewer and enlarged secretory vesicles (SV) predominantly encapsu-
lating the white content and there were fewer dark vesicles than in 
the controls. On the other hand, the cell size and nuclear appearance 
were unchanged in the DM group. In the insulin-treated group, the 
predominant white vesicular coloration in the DM group was less 
evident, but there were fewer black SVs than in the apical areas of 
the acinar cells of the control LGs (Figure 2).
RT-PCR revealed that the Rab 3d, Rab 27b, and Rab 23 mRNA 
levels were not changed by DM or insulin treatment, but the Vamp 2 
level was higher in the insulin-treated group (Figure 3).
Western blotting revealed that the expression of syntaxin 1, Rab 
27b, and Rab 3d were significantly lower in the DM group, whereas 
the decline in Vamp 2 was insignificant. However, insulin treatment 
prevented the declines in Rab 27b, syntaxin 1, and Rab 3d expression as 
they remained at levels similar to those in the control group (Figure 4).
DISCUSSION
The present study indicated that there was a correspondence 
between changes in the secretory mechanisms in LGs that were iso-
Table 2. Antibodies used for Western blot analysis of SNARE and Rab 
protein detection in LG of control, DM, and insulin-treated DM rats
Protein Catalog # Type
Molecular 
weight Concentration
GAPDH Santa Cruz Rabbit polyclonal 37 KDa 200 μg/mL
SC 367715
Rab 3 d Santa Cruz Goat polyclonal 25 KDa 200 μg/mL
SC 26392
Rab 27b Santa Cruz Goat polyclonal 30 KDa 200 μg/mL
SC 22993
Vamp 2 Calbiochem Rabbit polyclonal 12 KDa 1 mg/mL
627724
Syntaxin Santa Cruz Mouse monoclonal 35 KDa 200 μg/mL
SC 12736
Table 3. Changes in parameters of the control, DM, and insulin-treated 
DM rats. Data is expressed as mean ± standard error, *denotes p<0.05 
Control DM DM-ins
Body weight (g) 699.8 ± 25.02 205.20 ± 11.37* 504.0 ± 54.67
LG weight (mg) 128.2 ± 04.83 050.10 ± 01.87* 097.0 ± 08.61
Glycemia (mg/dL) 156.5 ± 12.65 542.30 ± 53.53* 295.3 ± 38.15
Acetylcholine (µM) 110.6 ± 18.60 086.70 ± 13.50* 117.6 ± 16.50
Figure 2. Transmission electron microscopy of the acinar cells in the exorbital LG of control 
(A, D), DM (B, E), and insulin-treated (C, F) DM groups. The images are representative of 
sections of LGs from 5 animals/group. Magnification ×2000 in the upper lane and ×4000 
in the lower lane (scale bar=5 µm and 2.5 µm, respectively). 
A
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Figure 3. Insulin replacement increased the mRNA content of Vamp2. RT-PCR of (A) 
Rab27b, (B) Rab3d, (C) Vamp2, and (D) Rab 23 in LGs of the control, DM, and insulin-treated 
DM rats. Densitometric arbitrary units were normalized to β-actin expression and were 
expressed as mean ± standard error of the mean (*denotes p value <0.05). Results are 
representative of three independent experiments (n=5/group/experiment). 
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Figure 4. Impaired expression of SNARE and Rab proteins was rescued by insulin treat-
ment in LG of diabetic rats. Western blotting of (A) Vamp2, (B) syntaxin 1, (C) Rab27b, 
and (D) Rab3d in LGs of control, DM, and insulin-treated DM rats. Densitometric arbitrary 
units were normalized to GAPDH expression. Data are expressed are means ± standard 
error of the mean; * p<0.05. Results are representative of three independent experiments 
(n = 5/group/experiment).
lated from DM rats and the dry eye syndrome manifestations. Such 
an insight will provide a better understanding of dry eye pathophy-
siology(7,12,21). The major current finding was that lower intracellular 
transport protein expression levels in the DM group were associated 
with declines in delimited SV density and their ultra-structural appea-
rance of the acinar apical cell membranes. 
Different animal models of DM have found that LG secretory 
product content changes can accompany OS neuronal and struc-
tural damage(24). Taken together, the present findings, in particular, 
the similar levels of ACh among the diabetic and control groups, 
suggested that the damage in the signaling machinery of diabetic LG 
preceded the neurogenic damage to the LG and OS(25). These results 
are consistent with a previous study where LG synaptic junctional 
ultrastructure of the DM rats were preserved after 4 weeks of disease, 
although the insulin signaling cascade was already impaired just 1 
week after DM onset(8,26). 
Although animal models in general have some limitations in fully 
simulating a disease condition (e.g., dry eye syndrome), in streptozo-
tocin-diabetic rats, these structural changes were described in the 
secretory granules of the acinar cells of LGs along with the functional 
impairment(24). Moreover, in different models of diabetic rodents, me-
chanisms other than those described here triggered declines in tear 
secretion and corneal epithelial damage associated with inflamma-
tion, lower proliferative capacity, and oxidative damage(27).
The fact that in LGs of DM rats there is a discrepancy between 
the declines in Rab 3d and Rab 27 protein expression and the lack 
of changes in their mRNA expression suggested that DM promoted 
chan ges at a post-transcriptional level. They may be caused by a 
re duction in translational events or a decline in the protein half-life. 
Such decreases could be attributable to hyperglycemia or a secondary 
vascular disturbance(28). 
In an aging rodent, which is another model of the dry eye syndro-
me, similar alterations in SV appearance and declines in their density 
were associated with lower Rab 3d levels(20). Similar to the DM model 
used here, this model had high levels of oxidative stress and insulin 
resistance(19,21). As in that study, we were unable to identify syntaxin 1 
at the mRNA levels, but detected it with Western blotting. A possible 
explanation was that the antibody that we used cross-reacted with 
another LG acinar cell syntaxin isoform, which we did not probe for 
at the mRNA level. 
A recent publication revealed that SV were highly expressed in 
human LGs with dry eye induced by prolonged visual display terminal 
exposure compared to controls and Sjögren’s syndrome patients. Taken 
together, those findings indicated that distinct diseases differentially 
affected the LG secretory mechanisms, as did evaporative, inflam-
matory, and diabetic dry eye. In agreement with those findings in 
humans subject to video display terminals or Sjogren’s syndrome, 
the present work revealed that Vamp-2 increased in a DM model of 
dry eye and the SV were dimorphic; their localization was changed in 
the acinar cells of LG. This observation may indicate that therapeutic 
mea sures to prevent such changes could compensate for the abnor-
mal secretory changes induced by DM. Insulin induced multiple 
res ponses through a myriad of interacting intracellular signaling cas-
cades(29). It was demonstrated that either systemic insulin or topical 
treatment prevented LG damage and reduced ocular surface dama-
ge in DM animal models with dry eye(21). In the present work, systemic 
insulin was sufficient to protect against body and LG weight loss due to 
increases in catabolism and more severe SV content and ultra-structural 
changes along with modified secretory protein profiles(30).
In conclusion, the present work demonstrated that the LG secre-
tory impairment secondary to DM was involved in reducing the ex-
pression of some Rab and SNARE protein family members that were 
responsible for intracellular SV trafficking that could be prevented by 
insulin treatment. The consequent reduction in tear secretion and 
content in the untreated DM rats may help to explain early ocular 
surface epithelial damage in DM(21). Moreover, the present findings 
may help to identify new therapeutic measures in DM for use in the 
dry eye syndrome, including insulin hormone therapy.
eThicAl sTAndArds
All experimental procedures adhered to the Principles of Labo-
ra tory Animal Care (NIH publication no. 85 to 23) and the ARVO Sta -
tement for the Use of Animals in Ophthalmic and Vision Research and 
were approved by the committee on animal experimentation of the 
School of Medicine at Ribeirão Preto, University of São Paulo. 
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